Bottom line
Is TRUH a good fund? The bottom line
TRUH is a managed health care sector ETF from VanEck.
Annual fees run 0.1% — about $10 a year on every $10,000 invested, cheaper than 96% of health care sector funds we track.
With $833,118 in net assets and 60 holdings, its largest position is Eli Lilly & Co (16.6%) and the top 10 make up 61.7% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 100% top-holdings overlap).
What stands out
- Low cost: cheaper than 96% of health care sector peers
What to watch
- Concentrated: top 10 holdings are 61.7% of assets
- Small fund ($833,118) — small funds are likelier to close
Updated Nov 19, 2026
What TRUH invests in
The objective of VanEck Healthcare TruSector ETF (the Fund) is long-term capital appreciation.
"The Fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing, under normal market circumstances, at least 80% of its total assets in equity securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies as determined by the Adviser. For purposes of this policy, the term assets means net assets plus the amount of any borrowings for investment purposes. Such companies may include those in the following industries: pharmaceuticals, biotechnology, life sciences tools and services, healthcare equipment and supplies, and healthcare providers and services. The Adviser utilizes a discretionary investment process that favors investments in healthcare-related companies that are well-established market leaders, considering factors such as industry dominance, large market capitalization, high…
From the fund's prospectus (filed Feb 20, 2026).
What TRUH costs
On a $10,000 investment, TRUH's 0.1% expense ratio costs about $10 a year. The median health care sector fund charges 0.96%.
TRUH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co | 16.56% |
| 2 | Johnson & Johnson | 10.67% |
| 3 | AbbVie Inc | 7.76% |
| 4 | UnitedHealth Group Inc | 6.59% |
| 5 | Merck & Co Inc | 5.54% |
| 6 | Amgen Inc | 3.39% |
| 7 | Thermo Fisher Scientific Inc | 3.25% |
| 8 | Abbott Laboratories | 2.76% |
| 9 | Gilead Sciences Inc | 2.74% |
| 10 | Intuitive Surgical Inc | 2.48% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 61.7% of the fund. See all top 25 holdings and asset mix →
Alternatives to TRUH
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 100% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 98% | Compare |
| Vanguard | VHT Vanguard Health Care Index Fund | 0.09% | 94% | Compare |
| iShares | IYH iShares U.S. Healthcare ETF | 0.37% | 90% | Compare |
| J.P. Morgan | JDOC JPMorgan Healthcare Leaders ETF | 0.65% | 62% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 76% | Compare |